NicholasJohnMaragakisMD

Neurophysiology

Professor of Neurology, Johns Hopkins University School of Medicine; Co-director, Michael S. and Karen G. Ansari ALS Center for Cell Therapy and Regeneration Research

Join to view full profile

Dr. Maragakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maragakis' full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-9441

Education & Training

Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1998 - 1999
Johns Hopkins UniversityResidency, Neurology, 1995 - 1998
University of Utah HealthInternship, Internal Medicine, 1994 - 1995
University of Utah School of MedicineClass of 1994

Certifications & Licensure

MD State Medical License 1998 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2012 Jan 01
Completed
Not Applicable
Clinical Trial of Ezogabine (Retigabine) in ALS Subjects Start of enrollment: 2015 Jun 01
Completed
Phase 2
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS Start of enrollment: 2020 May 28
Recruiting
Phase 2, Phase 3
A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation Start of enrollment: 2021 May 17
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

57 citations
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
Namita Goyal, James D. Berry, Anthony J. Windebank, Nathan P. Staff, Nicholas J. Maragakis
Muscle & Nerve. 2020-08-01
110 citations
Multipoint incremental motor unit number estimation as an outcome measure in ALS
Jeremy M. Shefner, Mary Lou Watson, L. Simionescu, James B. Caress, Ted M. Burns
Neurology. 2011-07-19
26 citations
Role of Human-Induced Pluripotent Stem Cell-Derived Spinal Cord Astrocytes in the Functional Maturation of Motor Neurons in a Multielectrode Array System
Arens Taga, Raha Dastgheyb, Christa W. Habela, Jessica Joseph, Jean Philippe Richard
Stem Cells Translational Medicine. 2019-12-01

Journal Articles

Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis
Brian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
Motor Neuron-Derived microRNAs Cause Astrocyte Dysfunction in Amyotrophic Lateral Sclerosis
Jeffrey D Rothstein, Nicholas J Maragakis, Timothy M Miller, Brain

Other

Motoneuron Disease: Clinical
Nicholas Maragakis, MD, Springer
https://www.doximity.com/articles/11995bea-a048-4cec-bc0f-7564c791758a
UpToDate, Wolters Kluwer Health - 2012-10-23

Press Mentions

Johns Hopkins Researchers Identify Potential Window for Treating ALSApril 8th, 2022
Potential Window for Treating ALS Identified — ScienceDailyMarch 29th, 2022
Johns Hopkins Researchers Identify a Potential Window for Treating ALSMarch 29th, 2022
Join now to see all